Evotec SE (EVO) Long-Term Deferred Tax (2020 - 2026)
Evotec SE's (EVO) quarterly Long-Term Deferred Tax came in at $2.2 million in Q2 2026, down 88.33% year-over-year from $18.8 million in Q2 2025, and up 11.3% quarter-over-quarter from $2.0 million in Q1 2026.
Analysis
Evotec SE (EVO) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $2.2 million for Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 88.33% year-over-year to $2.2 million; the TTM figure through Jun 2026 stood at $2.2 million (down 88.33% YoY), while the FY2025 annual figure was $3.3 million, down 82.24% from the prior year.
- Long-Term Deferred Tax came in at $2.2 million for Q2 2026 at Evotec SE, up from $2.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $39.6 million in Q3 2024 to a low of $2.0 million in Q1 2026.
- Average Long-Term Deferred Tax over 5 years is $15.1 million, with a median of $15.8 million recorded in 2023.
- Year-over-year, Long-Term Deferred Tax surged 46.34% in 2023 and tumbled 88.53% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $10.5 million in 2022, then jumped by 46.34% to $15.4 million in 2023, then rose by 20.13% to $18.5 million in 2024, then sank by 81.47% to $3.4 million in 2025, then sank by 36.0% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $2.2 million in Q2 2026, $2.0 million in Q1 2026, and $3.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 18.82 Mn |
| Mar 31, 2025 | 17.21 Mn |
| Dec 31, 2024 | 18.52 Mn |
| Sep 30, 2024 | 39.60 Mn |
| Mar 31, 2024 | 23.71 Mn |
| Dec 31, 2023 | 15.42 Mn |
| Jun 30, 2023 | 12.39 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 16.17 Mn |
| Mar 31, 2022 | 18.25 Mn |
| Dec 31, 2021 | 19.86 Mn |
| Sep 30, 2021 | 29.15 Mn |
| Dec 31, 2020 | 29.08 Mn |